147 related articles for article (PubMed ID: 36810620)
21. Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D.
Carrara D; Bernini M; Bacca A; Rugani I; Duranti E; Virdis A; Ghiadoni L; Taddei S; Bernini G
J Renin Angiotensin Aldosterone Syst; 2014 Mar; 15(1):82-7. PubMed ID: 23283825
[TBL] [Abstract][Full Text] [Related]
22. RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
Beger C; Karg T; Hinrichs JB; Ringe B; Haller H; Meyer BC; Limbourg FP
Blood Press; 2023 Dec; 32(1):2179340. PubMed ID: 36803263
[TBL] [Abstract][Full Text] [Related]
23. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
[TBL] [Abstract][Full Text] [Related]
24. Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus.
Yoneda T; Takeda Y; Usukura M; Oda N; Takata H; Yamamoto Y; Karashima S; Yamagishi M
Am J Hypertens; 2007 Dec; 20(12):1329-33. PubMed ID: 18047925
[TBL] [Abstract][Full Text] [Related]
25. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
26. Renin-angiotensin-aldosterone system.
Dillon MJ
Eur J Clin Pharmacol; 1980 Jul; 18(1):105-8. PubMed ID: 6249611
[TBL] [Abstract][Full Text] [Related]
27. Renal artery occlusive disease, renin-angiotensin-aldosterone, inflammation, and refractory arterial hypertension, a half-century's perspective.
Stanley JC
J Vasc Surg; 2022 Jul; 76(1):46-52. PubMed ID: 35257797
[No Abstract] [Full Text] [Related]
28. Blood pressure and the renin--angiotensin--aldosterone system.
Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():261s-263s. PubMed ID: 7032815
[TBL] [Abstract][Full Text] [Related]
29. The incidence and implications of aldosterone breakthrough.
Bomback AS; Klemmer PJ
Nat Clin Pract Nephrol; 2007 Sep; 3(9):486-92. PubMed ID: 17717561
[TBL] [Abstract][Full Text] [Related]
30. Acute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension.
Hiramatsu K; Yamagishi F; Kubota T; Yamada T
Am Heart J; 1982 Dec; 104(6):1346-50. PubMed ID: 6293295
[TBL] [Abstract][Full Text] [Related]
31. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
[TBL] [Abstract][Full Text] [Related]
32. [Renin-angiotensin-aldosterone system in hypertension patients who have had a cerebral stroke].
Fedirko MI; Ershova GS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1321-3. PubMed ID: 3321797
[TBL] [Abstract][Full Text] [Related]
33. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
Pagny JY; Thibonnier M; Corvol P; Menard J
J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S82-5. PubMed ID: 2412019
[TBL] [Abstract][Full Text] [Related]
34. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
[TBL] [Abstract][Full Text] [Related]
35. Reply to comments about "Aldosterone breakthrough".
Mogi M
Hypertens Res; 2023 May; 46(5):1351-1352. PubMed ID: 36810622
[No Abstract] [Full Text] [Related]
36. TASK-3 channel deletion in mice recapitulates low-renin essential hypertension.
Guagliardo NA; Yao J; Hu C; Schertz EM; Tyson DA; Carey RM; Bayliss DA; Barrett PQ
Hypertension; 2012 May; 59(5):999-1005. PubMed ID: 22493079
[TBL] [Abstract][Full Text] [Related]
37. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
Bovée DM; Uijl E; Severs D; Rubio-Beltrán E; van Veghel R; Maassen van den Brink A; Joles JA; Zietse R; Cuevas CA; Danser AHJ; Hoorn EJ
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F654-F668. PubMed ID: 33586496
[TBL] [Abstract][Full Text] [Related]
38. The relationship of plasma renin, angiotensin, and aldosterone levels to blood pressure variability and target organ damage in children with essential hypertension.
Liu Y; Lin Y; Zhang MM; Li XH; Liu YY; Zhao J; Shi L
BMC Cardiovasc Disord; 2020 Jun; 20(1):296. PubMed ID: 32546130
[TBL] [Abstract][Full Text] [Related]
39. [ON THE IMPORTANCE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE PATHOGENESIS OF RENAL HYPERTENSION].
BOGATZKI M
Med Klin; 1964 Jun; 59():1046-8. PubMed ID: 14243291
[No Abstract] [Full Text] [Related]
40. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
